LAVA Therapeutics(US:LVTX) Prnewswireยท2025-08-07 22:29Group 1 - Class Action Attorney Juan Monteverde's firm has recovered millions for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1] - The firm is investigating LAVA Therapeutics N.V. regarding its sale to XOMA Royalty Corporation, which proposes to acquire LAVA for $1.16 in cash per share, plus up to $0.08 per share and a contingent value right [1] - The contingent value right represents the right to receive 75% of the net proceeds from LAVA's partnered assets and 75% of any net proceeds from out-licensed programs [1] Group 2 - Monteverde & Associates PC is a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court [2] - The firm operates from the Empire State Building in New York City [2]